Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1963 2
1966 1
1967 2
1968 3
1969 1
1970 3
1971 2
1972 1
1974 2
1975 1
1976 3
1977 1
1978 2
1979 5
1980 6
1981 12
1982 12
1983 9
1984 16
1985 24
1986 30
1987 20
1988 33
1989 31
1990 39
1991 35
1992 46
1993 38
1994 48
1995 53
1996 52
1997 53
1998 37
1999 54
2000 56
2001 68
2002 63
2003 54
2004 54
2005 76
2006 69
2007 86
2008 73
2009 86
2010 61
2011 54
2012 66
2013 81
2014 53
2015 63
2016 53
2017 75
2018 77
2019 80
2020 96
2021 78
2022 77
2023 74
2024 47
2025 73
2026 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,308 results

Results by year

Filters applied: . Clear all
Page 1
An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study.
Kadowaki S, Otsuka T, Minashi K, Nishina S, Yabusaki H, Inagaki C, Nishina T, Yasui H, Matsuoka H, Machida N, Tsuda M, Nagashima F, Hosaka H, Matsubara J, Arai H, Ida S, Kimijima Y, Matsuda Y, Muto M, Muro K. Kadowaki S, et al. Among authors: matsuoka h. Gastric Cancer. 2025 Sep;28(5):955-967. doi: 10.1007/s10120-025-01641-7. Epub 2025 Jul 9. Gastric Cancer. 2025. PMID: 40632416 Free PMC article.
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.
Kawazoe A, Yamaguchi K, Hamaguchi T, Narita Y, Boku S, Oshima T, Hara H, Hamamoto Y, Ishido K, Esaki T, Hosaka H, Yasui H, Koeda K, Nishina T, Tsuji Y, Fukagawa T, Goto M, Oki E, Sugimoto N, Matsuoka H, Yokoyama F, Yoshida T, Yoshida K, Oshima Y, Iwasa S. Kawazoe A, et al. Among authors: matsuoka h. Cancer Sci. 2025 Sep;116(9):2523-2536. doi: 10.1111/cas.70130. Epub 2025 Jul 6. Cancer Sci. 2025. PMID: 40618725 Free PMC article. Clinical Trial.
P2Y12 Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRAS.
Fujimoto S, Iguchi Y, Yamagami H, Koga M, Itabashi R, Yakushiji Y, Kowata K, Kimura N, Terasawa Y, Shimizu T, Miyazaki Y, Oki K, Masuo O, Matsuoka H, Arakawa S, Ueda T, Tanaka R, Hashimoto W, Abe S, Kato G, Furugori T, Kimura K; ACUTE-PRAS Investigators. Fujimoto S, et al. Among authors: matsuoka h. Circ J. 2025 Nov 25;89(12):1922-1930. doi: 10.1253/circj.CJ-24-0949. Epub 2025 May 16. Circ J. 2025. PMID: 40383626 Free article. Clinical Trial.
Coping well.
Tu TTH, Toyofuku A, Matsuoka H. Tu TTH, et al. Among authors: matsuoka h. Br Dent J. 2020 Jul;229(2):70. doi: 10.1038/s41415-020-1931-x. Br Dent J. 2020. PMID: 32710019 Free PMC article. No abstract available.
Metabolome Profiling of Yokukansan in Preventing Postoperative Delirium in Elderly Cancer Patients: A Reverse Translational Study.
Sadahiro R, Ohbuchi K, Nakaya T, Manabe S, Wada S, Yamaguchi T, Sugimoto M, Shimizu K, Sato T, Esaki M, Daiko H, Yoshimoto S, Kanemitsu Y, Kawai A, Ishikawa M, Matsui Y, Aoki K, Ueno T, Matsuoka H, Uezono Y. Sadahiro R, et al. Among authors: matsuoka h. Psychiatry Clin Neurosci. 2025 Oct;79(10):685-696. doi: 10.1111/pcn.13875. Epub 2025 Aug 5. Psychiatry Clin Neurosci. 2025. PMID: 40765131 Free PMC article. Clinical Trial.
Layer-Number-Independent Two-Dimensional Ferromagnetism in Cr3Te4.
Wang Y, Kajihara S, Matsuoka H, Saika BK, Yamagami K, Takeda Y, Wadati H, Ishizaka K, Iwasa Y, Nakano M. Wang Y, et al. Among authors: matsuoka h. Nano Lett. 2022 Dec 28;22(24):9964-9971. doi: 10.1021/acs.nanolett.2c03532. Epub 2022 Dec 14. Nano Lett. 2022. PMID: 36516275
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer.
Terada N, Koba H, Nanjo S, Kimura H, Nishiyama A, Yoneda T, Takeda T, Shirasaki H, Nishi K, Sone T, Yamada T, Takayama K, Shibata K, Matsuoka H, Kita T, Nagata K, Tambo Y, Ohkura N, Hara J, Kasahara K, Kohsaka S, Mano H, Yano S. Terada N, et al. Among authors: matsuoka h. Transl Lung Cancer Res. 2024 Nov 30;13(11):3067-3082. doi: 10.21037/tlcr-24-471. Epub 2024 Nov 28. Transl Lung Cancer Res. 2024. PMID: 39670006 Free PMC article.
Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.
Kameda T, Shide K, Tahira Y, Sekine M, Sato S, Ishizaki J, Takeuchi M, Akizuki K, Kamiunten A, Shimoda H, Toyama T, Maeda K, Yamashita K, Kawano N, Kawano H, Hidaka T, Yamaguchi H, Kubuki Y, Kitanaka A, Matsuoka H, Shimoda K. Kameda T, et al. Among authors: matsuoka h. Viruses. 2022 Mar 29;14(4):710. doi: 10.3390/v14040710. Viruses. 2022. PMID: 35458440 Free PMC article.
Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study).
Akechi T, Furukawa TA, Noma H, Iwata H, Toyama T, Higaki K, Matsuoka H, Zenda S, Iwatani T, Akahane K, Inoue A, Sagara Y, Uchida M, Imai F, Momino K, Imaizumi G, Yamaguchi T, Mashiko T, Miyaji T, Horikoshi M, Sakurai N, Onishi T, Kanemitsu Y, Murata T, Wanifuchi-Endo Y, Kuroda H, Nishikawa R, Miyashita M, Abe M, Uchitomi Y; J‐SUPPORT 2001 Study group. Akechi T, et al. Among authors: matsuoka h. Psychiatry Clin Neurosci. 2024 Jun;78(6):353-361. doi: 10.1111/pcn.13657. Epub 2024 Mar 11. Psychiatry Clin Neurosci. 2024. PMID: 38468404 Free PMC article. Clinical Trial.
2,308 results